Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin 500 mg SR (Sustained Release) Tablet is a triple-combination oral anti-diabetic medicine used for effective management of Type 2 Diabetes Mellitus in patients requiring intensive glycemic control.
No account yet?
Create an Account
the first to learn about our latest trends